We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Smiths Group Plc | LSE:SMIN | London | Ordinary Share | GB00B1WY2338 | ORD 37.5P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 15.00 | 0.89% | 1,702.00 | 1,701.00 | 1,702.00 | 1,708.00 | 1,684.00 | 1,684.00 | 781,293 | 16:35:27 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Srch,det,nav,guid,aero Sys | 3.04B | 231M | 0.6613 | 25.72 | 5.94B |
From May 2019 to May 2024
TIDMSMIN
RNS Number : 4369P
Smiths Group PLC
29 May 2018
News Release
London, 27 May 2018
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION
Sunday 27 May 2018
Smiths Group plc ("Smiths")
Statement regarding Smiths Medical
Smiths notes the press speculation regarding discussions involving its Smiths Medical business and confirms that it is in very early stage discussions about a potential combination of its medical division with ICU Medical, Inc. (NASDAQ: ICUI).
The Board of Smiths routinely reviews all options for the Group's portfolio of businesses to maximise value for Smiths shareholders.
There can be no certainty that a transaction will be concluded.
END
Contact details Investor enquiries Jemma Spalton, Smiths Marion Le Bot, Smiths Group Group +44 (0)20 7004 1637 +44 (0)20 7004 1672 +44 (0)78 6739 0350 +44 (0)75 8315 4386 jemma.spalton@smiths.com marion.lebot@smiths.com Media enquiries Deborah Scott, FTI Consulting Alex Le May, FTI Consulting +44 (0)20 3727 1459 +44 (0)20 3727 1308 +44 (0)797 953 7449 +44 (0)7702 443 312 smiths@fticonsulting.com smiths@fticonsulting.com
About Smiths Group
Smiths Group is a global technology company listed on the London Stock Exchange (SMIN) and operates a sponsored level one ADR programme (SMGZY). A world leader in the practical application of advanced technologies, Smiths Group delivers products and services for the medical technology, security & defence, general industrial, oil & gas, and space & aerospace markets worldwide. Smiths Group employs c.22,000 colleagues in over 50 countries. For more information visit www.smiths.com.
About Smiths Medical
Smiths Medical is a leading supplier of specialised medical devices and equipment for global markets, focusing on the medication delivery, vital care and safety devices market segments. For more information visit www.smiths-medical.com.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
STRAPMLTMBJTBMP
(END) Dow Jones Newswires
May 29, 2018 02:01 ET (06:01 GMT)
1 Year Smiths Chart |
1 Month Smiths Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
